Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

View ORCID ProfileMichael J. Peluso, Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer, Keirstinne Turcios, Owen Janson, Sadie E. Munter, Cassandra Thanh, Christopher C. Nixon, Rebecca Hoh, Viva Tai, Emily A. Fehrman, Yanel Hernandez, Matthew A. Spinelli, Monica Gandhi, Mary-Ann Palafox, Ana Vallari, Mary A. Rodgers, John Prostko, John Hackett Jr., Lan Trinh, Terri Wrin, Christos J. Petroplolous, Charles Y. Chiu, Philip J. Norris, Clara DiGermanio, Mars Stone, Michael P. Busch, Susanna K. Elledge, Xin X. Zhou, James A. Wells, Albert Shu, Theodore W. Kurtz, John E. Pak, Wesley Wu, Peter D. Burbelo, Jeffrey I. Cohen, Rachel L. Rutishauser, Jeffrey N. Martin, View ORCID ProfileSteven G. Deeks, Timothy J. Henrich, Isabel Rodriguez-Barraquer, Bryan Greenhouse
doi: https://doi.org/10.1101/2021.03.03.21251639
Michael J. Peluso
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael J. Peluso
Saki Takahashi
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill Hakim
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Daniel Kelly
2Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonel Torres
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
3Division of Experimental Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikita S. Iyer
3Division of Experimental Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keirstinne Turcios
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Owen Janson
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sadie E. Munter
3Division of Experimental Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cassandra Thanh
3Division of Experimental Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher C. Nixon
3Division of Experimental Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Hoh
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viva Tai
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily A. Fehrman
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanel Hernandez
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew A. Spinelli
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Gandhi
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary-Ann Palafox
4Abbott Laboratories, Abbott Park, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Vallari
4Abbott Laboratories, Abbott Park, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary A. Rodgers
4Abbott Laboratories, Abbott Park, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Prostko
4Abbott Laboratories, Abbott Park, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Hackett Jr.
4Abbott Laboratories, Abbott Park, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lan Trinh
5Monogram Biosciences, Inc., South San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terri Wrin
5Monogram Biosciences, Inc., South San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christos J. Petroplolous
5Monogram Biosciences, Inc., South San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Y. Chiu
6Department of Laboratory Medicine, University of California, San Francisco, USA
7Division of Infectious Diseases, University of California, San Francisco, USA
8UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip J. Norris
9Vitalant Research Institute, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clara DiGermanio
9Vitalant Research Institute, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mars Stone
9Vitalant Research Institute, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Busch
6Department of Laboratory Medicine, University of California, San Francisco, USA
9Vitalant Research Institute, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susanna K. Elledge
10Department of Pharmaceutical Chemistry, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin X. Zhou
10Department of Pharmaceutical Chemistry, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James A. Wells
10Department of Pharmaceutical Chemistry, University of California, San Francisco, USA
11Department of Cellular & Molecular Pharmacology, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Shu
6Department of Laboratory Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theodore W. Kurtz
6Department of Laboratory Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John E. Pak
12Chan Zuckerberg Biohub, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wesley Wu
12Chan Zuckerberg Biohub, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter D. Burbelo
13National Institute of Dental Research, National Institutes of Health, Bethesda, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey I. Cohen
14Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rachel L. Rutishauser
3Division of Experimental Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey N. Martin
2Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven G. Deeks
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Steven G. Deeks
Timothy J. Henrich
3Division of Experimental Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Rodriguez-Barraquer
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan Greenhouse
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bryan.greenhouse@ucsf.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Serosurveillance studies are critical for estimating SARS-CoV-2 transmission and immunity, but interpretation of results is currently limited by poorly defined variability in the performance of antibody assays to detect seroreactivity over time in individuals with different clinical presentations. We measured longitudinal antibody responses to SARS-CoV-2 in plasma samples from a diverse cohort of 128 individuals over 160 days using 14 binding and neutralization assays. For all assays, we found a consistent and strong effect of disease severity on antibody magnitude, with fever, cough, hospitalization, and oxygen requirement explaining much of this variation. We found that binding assays measuring responses to spike protein had consistently higher correlation with neutralization than those measuring responses to nucleocapsid, regardless of assay format and sample timing. However, assays varied substantially with respect to sensitivity during early convalescence and in time to seroreversion. Variations in sensitivity and durability were particularly dramatic for individuals with mild infection, who had consistently lower antibody titers and represent the majority of the infected population, with sensitivities often differing substantially from reported test characteristics (e.g., amongst commercial assays, sensitivity at 6 months ranged from 33% for ARCHITECT IgG to 98% for VITROS Total Ig). Thus, the ability to detect previous infection by SARS-CoV-2 is highly dependent on the severity of the initial infection, timing relative to infection, and the assay used. These findings have important implications for the design and interpretation of SARS-CoV-2 serosurveillance studies.

Competing Interest Statement

M-AP, AV, MAR, JP, JH are employees of Abbott Laboratories. LT, TW, and CJP are employees of Monogram Biosciences, Inc., a division of LabCorp. C.Y.C. is the director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC) and receives research support funding from the Abbott Laboratories Inc.TJH reports grants from Merck and Co., Gilead Biosciences, and Bristol-Myers Squibb outside the submitted work. MJP, ST, JH, JDK, LT, NSI, KT, OJ, SEM, CT, CCN, RH, VT, EF, YH, MAS, MG, SKE, XXZ, JAW, AS, TWK, JEP, WW, RLR, JNM, SGD, IRB, and BG have no interests to declare.

Clinical Trial

NCT04362150

Funding Statement

Funding: This work was supported by the National Institute of Allergy and Infectious Diseases (NIH/NIAID 3R01AI141003-03S1 [to TJ Henrich], NIH/NIAID R01AI158013 [to M Gandhi and M Spinelli] and by the Zuckerberg San Francisco Hospital Department of Medicine and Division of HIV, Infectious Diseases, and Global Medicine. MJP is supported on NIH T32 AI60530-12 and by the UCSF Resource Allocation Program. ST is supported by the Schmidt Science Fellows, in partnership with the Rhodes Trust. IRB and ST acknowledge research funding from the MIDAS Coordination Center COVID-19 Urgent Grant Program (MIDASNI2020-5). PDB is supported by the Intramural Research Program of the National Institute of Dental Research and JIC is supported by the National Institute of Allergy and Infectious Diseases. CYC is supported in part by NIH grants R01 HL105704 from the National Heart, Lung, and Blood Institute, R33- 29077 (C.Y.C.), and Abbott Laboratories. BG and JAW are supported in part by the Chan Zuckerberg Biohub Investigator Fund, XZ was supported by Damon-Runyon Cancer Research Fellowship.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the UCSF IRB #20-30479. All subjects provided written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Raw antibody data at the participant and visit level are provided in Supplementary Tables 2 and 3.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J. Peluso, Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer, Keirstinne Turcios, Owen Janson, Sadie E. Munter, Cassandra Thanh, Christopher C. Nixon, Rebecca Hoh, Viva Tai, Emily A. Fehrman, Yanel Hernandez, Matthew A. Spinelli, Monica Gandhi, Mary-Ann Palafox, Ana Vallari, Mary A. Rodgers, John Prostko, John Hackett Jr., Lan Trinh, Terri Wrin, Christos J. Petroplolous, Charles Y. Chiu, Philip J. Norris, Clara DiGermanio, Mars Stone, Michael P. Busch, Susanna K. Elledge, Xin X. Zhou, James A. Wells, Albert Shu, Theodore W. Kurtz, John E. Pak, Wesley Wu, Peter D. Burbelo, Jeffrey I. Cohen, Rachel L. Rutishauser, Jeffrey N. Martin, Steven G. Deeks, Timothy J. Henrich, Isabel Rodriguez-Barraquer, Bryan Greenhouse
medRxiv 2021.03.03.21251639; doi: https://doi.org/10.1101/2021.03.03.21251639
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J. Peluso, Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer, Keirstinne Turcios, Owen Janson, Sadie E. Munter, Cassandra Thanh, Christopher C. Nixon, Rebecca Hoh, Viva Tai, Emily A. Fehrman, Yanel Hernandez, Matthew A. Spinelli, Monica Gandhi, Mary-Ann Palafox, Ana Vallari, Mary A. Rodgers, John Prostko, John Hackett Jr., Lan Trinh, Terri Wrin, Christos J. Petroplolous, Charles Y. Chiu, Philip J. Norris, Clara DiGermanio, Mars Stone, Michael P. Busch, Susanna K. Elledge, Xin X. Zhou, James A. Wells, Albert Shu, Theodore W. Kurtz, John E. Pak, Wesley Wu, Peter D. Burbelo, Jeffrey I. Cohen, Rachel L. Rutishauser, Jeffrey N. Martin, Steven G. Deeks, Timothy J. Henrich, Isabel Rodriguez-Barraquer, Bryan Greenhouse
medRxiv 2021.03.03.21251639; doi: https://doi.org/10.1101/2021.03.03.21251639

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1745)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (649)
  • Epidemiology (10770)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2927)
  • Geriatric Medicine (286)
  • Health Economics (530)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (740)
  • Hematology (289)
  • HIV/AIDS (626)
  • Infectious Diseases (except HIV/AIDS) (12493)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (318)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2625)
  • Public and Global Health (5331)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)